erlotinib hydrochloride has been researched along with nitroxoline in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (nitroxoline) | Trials (nitroxoline) | Recent Studies (post-2010) (nitroxoline) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 142 | 6 | 88 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | nitroxoline (IC50) |
|---|---|---|---|
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 4.723 | |
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | 8.962 | |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 6.357 | |
| Vif | Human immunodeficiency virus 1 | 46.53 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 46.53 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 0.98 | |
| Cystathionine gamma-lyase | Homo sapiens (human) | 7 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 6 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 0.055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cama, A; De Lellis, L; De Tursi, M; di Sebastiano, P; Florio, R; Lanuti, P; Marchisio, M; Massucci, A; Natoli, C; Tinari, N; Veschi, S | 1 |
1 other study(ies) available for erlotinib hydrochloride and nitroxoline
| Article | Year |
|---|---|
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Erlotinib Hydrochloride; Humans; Nelfinavir; Nitroquinolines; Pancreatic Neoplasms | 2018 |